tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Steinberg, 113 are a BUY (84.33%), 21 are a HOLD (15.67%).
Analyst David Steinberg, carries an average stock price target met ratio of 69.45% that have a potential upside of 29.33% achieved within 255 days. Previously, David Steinberg worked at JEFFERIES.
David Steinberg’s has documented 254 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BHC, Bausch Health Companies at 20-Sep-2023.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for SUPN (SUPERNUS PHARMACEUTICALS) at 6/15/2020. The price target of $24 was fulfilled within 1 day with a profit of $0.93 (4.03%) receiving and performance score of 40.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3 months 4 days ago
(23-Dec-2024)
0/5 (0%)
$34.34 (396.54%)
Buy
$8
$6.4 (400.00%)
4 months 8 days ago
(19-Nov-2024)
0/3 (0%)
$3.41 (74.29%)
Buy
$7
$5.4 (337.50%)
4 months 8 days ago
(19-Nov-2024)
1/4 (25%)
$2.41 (52.51%)
315
Buy
$13
$11.4 (712.50%)
$2
4 months 9 days ago
(18-Nov-2024)
1/5 (20%)
$9.86 (314.01%)
354
Hold
$1
$-0.6 (-37.50%)
$2
1 years 3 months 9 days ago
(18-Dec-2023)
2/4 (50%)
$0.06 (6.38%)
178
What Year was the first public recommendation made by David Steinberg?
